| Introduction |
Dr. J.T. Callaghan |
| Introduction to Pharmacokinetics |
Dr. R.F. Bergstrom |
| PK/PD |
Dr. R.F. Bergstrom |
| Pharmacokinetics Basic Concepts and Applications |
Dr. S. Hall |
| Phase I Metabolism and Enzymology (System) (1) |
Dr. A. Borel |
| Role of Modeling and Simulation in Drug Development |
Dr. V. Sinha |
| Drug Transporters |
Dr. K. Hilgren |
| Renal Aspects of Drug Disposition |
Dr. J. Voelker |
| Phase I Metabolism and Enzymology (System) (II) |
Dr. J. Grace |
| Phase II Metabolism and Enzymology (GT&ST) |
TBA |
| Understanding Molecular Biology |
Dr. T. Skaar |
| Inhibition |
Dr. D. Jones |
| Genetic Modulation of Drug Metabolism (Clinical) |
Dr. J.T. Callaghan |
| Induction |
Dr. S. Wrighton |
| In vitro Drug Metabolism Methodology |
Mrs. Barb Ring |
| Metabolism Studies in Drug Discovery and Development (Why, When and How) |
Dr. C. McMillian |
| Toxicologic Consequences of Drug Metabolilsm |
Dr. J. Stevens |
| Clinical Significance of Drug Metabolsim |
Dr. J.T. Callaghan |
| Drug Measurement I - Principles of Chromatography |
Dr. M.P. Knadler |
| Pharmacogenetics of Receptors and Signaling Systems |
Dr. D. Flockhart |
| Surrogates and Biomarkers |
Dr. D. Flockhart |
| LC/MS, NMR and New Techniques in Drug Metabolism |
Dr. A. Chaudhary |
| Drug Measurement II - Radio- and stable-isotopes |
Dr. N. Faridt |
| Summary and Review |
Dr. S. Hall |